Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as of August 2026.

Metatag Title
World Largest HealthCare Products Companies in 2026
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2026, World Largest HealthCare Products Companies by Market Cap in 2026.
  1. Shenzhen Salubris Pharmaceuticals

    World Rank (Aug-2026)
    3,421
    Market Cap (Aug-2026)
    5.420 Billion USD
    World Rank (Jan-05-2024)
    2,903
    Market Cap (Jan-05-2024)
    5.028 Billion USD
    World Rank (Jul-30-2023)
    2,838
    Market Cap (Jul-30-2023)
    5.247 Billion USD
    World Rank (Dec-25-2022)
    2,715
    Market Cap (Dec-25-2022)
    5.016 Billion USD
    World Rank (Jan-07-2022)
    3,506
    Market Cap (Jan-07-2022)
    4.60 Billion USD
    Annual Revenue in USD
    581 Million USD
    Annual Operating Income in USD
    112 Million USD
    Annual Net Income in USD
    87 Million USD
    Annual Results for Period Ending
    For year ending December-2024
    Headquarters Country
    Company Profile
    Shenzhen Salubris Pharmaceuticals is a comprehensive pharmaceutical company that integrates pharmaceutical products research and development, production and business sales focuses on the therapeutic fields of cardiovascular, anti diabetic, antineoplastic and orthopedic as well as three mainlines of the high end chemical medicine, innovative biological medicines and medical apparatus and instruments. The company annual revenue is 416.07 million USD and 4,270 employees as on 2020. The headquarters is in China.
  2. Merit Medical Systems

    World Rank (Aug-2026)
    3,422
    Market Cap (Aug-2026)
    5.419 Billion USD
    World Rank (Jan-05-2024)
    3,267
    Market Cap (Jan-05-2024)
    4.365 Billion USD
    World Rank (Jul-30-2023)
    3,411
    Market Cap (Jul-30-2023)
    4.226 Billion USD
    World Rank (Dec-25-2022)
    3,240
    Market Cap (Dec-25-2022)
    4.033 Billion USD
    World Rank (Jan-07-2022)
    4,481
    Market Cap (Jan-07-2022)
    3.34 Billion USD
    Annual Revenue in USD
    1,516 Million USD
    Annual Operating Income in USD
    185 Million USD
    Annual Net Income in USD
    128 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Merit Medical Systems Manufacture and Market disposable Medical Devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. The headquarters is in USA.

  3. CRISPR Therapeutics AG

    World Rank (Aug-2026)
    3,545
    Market Cap (Aug-2026)
    5.178 Billion USD
    World Rank (Jan-05-2024)
    2,937
    Market Cap (Jan-05-2024)
    4.970 Billion USD
    World Rank (Jul-30-2023)
    3,257
    Market Cap (Jul-30-2023)
    4.491 Billion USD
    World Rank (Dec-25-2022)
    3,680
    Market Cap (Dec-25-2022)
    3.452 Billion USD
    World Rank (Jan-07-2022)
    3,187
    Market Cap (Jan-07-2022)
    5.18 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -665 Million USD
    Annual Net Income in USD
    -582 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.

    With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies

  4. MyoKardia

    World Rank (Aug-2026)
    3,600
    World Rank (Jan-05-2024)
    3,600
    World Rank (Jul-30-2023)
    3,600
    World Rank (Dec-25-2022)
    3,600
    World Rank (Jan-07-2022)
    3,600
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -288 Million USD
    Annual Net Income in USD
    -276 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    Company Profile

    MyoKardia is a Transformative Therapies company. It is applying a precision medicine approach to develop therapeutic candidates for patient populations with shared characteristics such as causal genetic mutations or disease subtypes. The headquarters is in USA.

    Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020.

     

    Facts About Company

    Bristol Myers Squibb acquired MyoKardia for 13.1 Billion USD in Nov-2020

  5. Guangzhou Baiyunshan Pharmaceutical Holdings Company

    World Rank (Aug-2026)
    3,605
    Market Cap (Aug-2026)
    5.058 Billion USD
    World Rank (Jan-05-2024)
    2,437
    Market Cap (Jan-05-2024)
    6.318 Billion USD
    World Rank (Jul-30-2023)
    2,247
    Market Cap (Jul-30-2023)
    6.926 Billion USD
    World Rank (Dec-25-2022)
    2,127
    Market Cap (Dec-25-2022)
    6.687 Billion USD
    World Rank (Jan-07-2022)
    2,231
    Market Cap (Jan-07-2022)
    8.07 Billion USD
    Annual Revenue in USD
    11,249 Million USD
    Annual Operating Income in USD
    513 Million USD
    Annual Net Income in USD
    432 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in China.
  6. Chongqing Zhifei Biological Products

    World Rank (Aug-2026)
    3,662
    Market Cap (Aug-2026)
    4.951 Billion USD
    World Rank (Jan-05-2024)
    938
    Market Cap (Jan-05-2024)
    19.341 Billion USD
    World Rank (Jul-30-2023)
    1,096
    Market Cap (Jul-30-2023)
    16.721 Billion USD
    World Rank (Dec-25-2022)
    855
    Market Cap (Dec-25-2022)
    19.561 Billion USD
    World Rank (Jan-07-2022)
    729
    Market Cap (Jan-07-2022)
    28.64 Billion USD
    Annual Revenue in USD
    1,298 Million USD
    Annual Operating Income in USD
    -438 Million USD
    Annual Net Income in USD
    -2,133 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Chongqing Zhifei Biological Products is Biotechnology company with nearly 3,000 employees, and assets of 13.6 billion yuan.

    In 2019, it achieved operating income of 10.59 billion yuan.

  7. ACADIA Pharmaceuticals

    World Rank (Aug-2026)
    3,702
    Market Cap (Aug-2026)
    4.866 Billion USD
    World Rank (Jan-05-2024)
    2,957
    Market Cap (Jan-05-2024)
    4.917 Billion USD
    World Rank (Jul-30-2023)
    3,125
    Market Cap (Jul-30-2023)
    4.723 Billion USD
    World Rank (Dec-25-2022)
    4,658
    Market Cap (Dec-25-2022)
    2.505 Billion USD
    World Rank (Jan-07-2022)
    4,217
    Market Cap (Jan-07-2022)
    3.63 Billion USD
    Annual Revenue in USD
    1,072 Million USD
    Annual Operating Income in USD
    105 Million USD
    Annual Net Income in USD
    391 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Acadia Pharmaceuticals is a Healthcare and Pharmaceutical company. The company is of food and drug administration for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Around 8 million people in the United States are living with dementia and studies suggest that approximately 30% of people with dementia, 2.4 million people, experience dementia-related hallucinations and delusion. The headquarters is in USA.

  8. Ajanta Pharma

    World Rank (Aug-2026)
    3,731
    Market Cap (Aug-2026)
    4.795 Billion USD
    World Rank (Jan-05-2024)
    3,979
    Market Cap (Jan-05-2024)
    3.395 Billion USD
    World Rank (Jul-30-2023)
    4,990
    Market Cap (Jul-30-2023)
    2.469 Billion USD
    World Rank (Dec-25-2022)
    5,749
    Market Cap (Dec-25-2022)
    1.835 Billion USD
    World Rank (Jan-07-2022)
    5,263
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    584 Million USD
    Annual Operating Income in USD
    143 Million USD
    Annual Net Income in USD
    114 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    Stock Category
    Company Profile
    Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The company annual revenue is 28,896 million INR and annual net income is 6,538 million INR as on 2021. The headquarters is in India.
  9. GlaxoSmithKline Pharmaceuticals (India)

    World Rank (Aug-2026)
    3,752
    Market Cap (Aug-2026)
    4.758 Billion USD
    World Rank (Jan-05-2024)
    3,326
    Market Cap (Jan-05-2024)
    4.282 Billion USD
    World Rank (Jul-30-2023)
    4,498
    Market Cap (Jul-30-2023)
    2.873 Billion USD
    World Rank (Dec-25-2022)
    4,390
    Market Cap (Dec-25-2022)
    2.735 Billion USD
    World Rank (Jan-07-2022)
    3,931
    Market Cap (Jan-07-2022)
    3.96 Billion USD
    Annual Revenue in USD
    411 Million USD
    Annual Operating Income in USD
    135 Million USD
    Annual Net Income in USD
    112 Million USD
    Annual Results for Period Ending
    For year ending March-2026
    Headquarters Country
    Stock Category
    Company Profile

    Glaxosmithkline Pharmaceuticals is a Pharmaceutical company with headquarters is in Mumbai, India.

  10. Shanghai Raas Blood Products

    World Rank (Aug-2026)
    3,769
    Market Cap (Aug-2026)
    4.728 Billion USD
    World Rank (Jan-05-2024)
    2,164
    Market Cap (Jan-05-2024)
    7.290 Billion USD
    World Rank (Jul-30-2023)
    2,243
    Market Cap (Jul-30-2023)
    6.950 Billion USD
    World Rank (Dec-25-2022)
    2,507
    Market Cap (Dec-25-2022)
    5.519 Billion USD
    World Rank (Jan-07-2022)
    2,449
    Market Cap (Jan-07-2022)
    7.26 Billion USD
    Annual Revenue in USD
    1,064 Million USD
    Annual Operating Income in USD
    243 Million USD
    Annual Net Income in USD
    228 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Biotechnology company with headquarters is in China.

Share

Ads